Treatment of acute, decompensated heart failure
The natriuretic peptide BNP and the inactive N-terminal fragment of its precursor, NT-proBNP, are used for both diagnostic and prognostic purposes in patients with heart failure or those suspected of heart failure. Susan Stienen carries out research into NT-proBNP-guided therapy in acute decompensated heart failure patients.
S. Stienen: NT-ProBNP-Guided Therapy in Acute Decompensated Heart Failure.
Prof. Y.M. Pinto
Dr W.E.M. Kok
Oudezijds Voorburgwal 229 - 231 | 1012 EZ AmsterdamGo to detailpage
+31 (0)20 525 2362
This event is open to the public.